Prevention of Stretch Marks in Expectant Mothers
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorStratpharma AG
About this trial
PRIME Mothers is a national observational trial designed to evaluate patient outcomes with Stratamark® for the prevention of stretch marks during pregnancy and the postpartum period. The study is designed to fit seamlessly into routine clinical practice, with digital follow-up and home resupply, minimising clinic involvement.
Eligibility criteria
Qualifiers
Pregnant women at any gestational age.
Participants who are in good health, including those that are carrying multiples, who are 18 years of age or older.
Confirmed absence of pre-existing stretch marks on the abdomen.
Agree to apply Stratamark according to the prescribed protocol for the duration of the study.
Disqualifiers
Visible stretch marks on the abdomen prior to enrollment.
Pre-existing skin conditions (e.g., eczema, psoriasis), on the abdomen that could interfere with product application or assessment of stretch marks.
Known hypersensitivity or allergy to any of the ingredients in Stratamark.
Use of other topical treatments on the abdomen, including but not limited to oils, or creams targeting stretch mark prevention.
Trial design
Treatments tested in this trial
- Stratamark
Treatment groups
10,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Stratpharma AG
Lead sponsor
St Andrew's War Memorial Hospital
Collaborator
Source ClinicalTrials.gov